Palliative MedicineEPIC-BSNCT06310889
Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project
An observational study of Palliative Medicine, run by Charite University, Berlin, Germany.
Trial summary
The subject of the study is an online survey of doctors and nurses who provide (intensive) medical care to patients. Read more about this study
- Who is it for?
- Ages 18 to 67 yearsHealthy volunteers can take part
- Conditions the study is for
- Palliative Medicine
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 1 Apr 2024to 30 Jun 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 67 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Doctors or nursing staff involved in the intensive medical care of patients which can be contacted by a list of a specialist association
Who may be able to join
- All doctors or nursing staff involved in the intensive medical care of patients and consent to the survey via the distribution list of a specialist association
Who cannot join
- Incomplete data
About this study
Official title: Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project (EPIC-Baseline-Survey)
The subject of the study is an online survey of doctors and nurses who provide (intensive) medical care to patients.
Read the detailed description
Charité will support this international survey as part of the preparatory phase of the "Europe-wide harmonized and recommended palliative care practice for ICU" approved HORIZON grant application EPIC (EA2/291/23), to which this ethics application refers.
Participants will be contacted via the mailing list of ESAIC (European Organization for Anaesthesia, Intensive Care, Pain and Perioperative Medicine), ESICM (European Society of Intensive Care Medicine), DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI) and the European Association for Palliative Care (EAPC).
- Conditions
- Palliative Medicine
What is being measured
The primary outcome is the main question the study is designed to answer.
Barriers 1
Barriers in palliative care regarding implementation of therapeutic goals (implementation rate symptom assessment for e.g. breathing and dyspnea).
Measured: 01.04.2024 - 30.06.2024
Barriers 2
Barriers in palliative care regarding implementation of patient automomy (implementation rate to define advance directives and power of attorney).
Measured: 01.04.2024 - 30.06.2024
Secondary outcomes (4)
Measures 1
Measures to be taken in the palliative medical treatment situation (implementation rate to define and document end-of-life-decisions).
Measured: 01.04.2024 - 30.06.2024
Measures 2
Evaluation of measures to be taken in the palliative medical treatment situation (family involvement in end-of-life-decisions).
Measured: 01.04.2024 - 30.06.2024
Resources 1
Personnel resources in palliative care (rate of specialized palliative care team available in ICUs).
Measured: 01.04.2024 - 30.06.2024
Resources 2
Other resources in palliative care (rate availability of psychological support)
Measured: 01.04.2024 - 30.06.2024
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Mar 2024
- Study start1 Apr 2024 (estimated)
- Primary completion30 Jun 2024 (estimated)
- Study completion30 Jun 2024 (estimated)
Why it stopped: Already registered
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Palliative MedicineStudies of the same condition, open and under way.
- More trials run by Charite University, Berlin, GermanyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Charite University, Berlin, Germany
- Sponsor type
- University, hospital or other
- Collaborators
- European Commission, National and Kapodistrian University of Athens, King's College Hospital NHS Trust
- Responsible party
- Principal investigator, Claudia Spies, Charite University, Berlin, Germany
- Investigators
- Claudia Spies, MD, Prof., Study chair, Charite University, Berlin, Germany
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06310889
- Sponsor's protocol ID
- EPIC-Baseline-Survey
- Acronym
- EPIC-BS
- Status last verified
- Mar 2024
- First submitted
- 22 Feb 2024
- Last updated
- 18 Mar 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project (EPIC-Baseline-Survey)
- ClinicalTrials.gov ID
- NCT06310889
- Acronym / sponsor ID
- EPIC-BS / EPIC-Baseline-Survey
- Conditions
- Palliative Medicine
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Already registered
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Charite University, Berlin, GermanyUniversity, hospital or other
- Collaborators
- European Commission, National and Kapodistrian University of Athens, King's College Hospital NHS Trust
- Study start
- 1 Apr 2024 (estimated)
- Primary completion
- 30 Jun 2024 (estimated)
- Study completion
- 30 Jun 2024 (estimated)
- First posted
- 15 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The subject of the study is an online survey of doctors and nurses who provide (intensive) medical care to patients.
Detailed description
Charité will support this international survey as part of the preparatory phase of the "Europe-wide harmonized and recommended palliative care practice for ICU" approved HORIZON grant application EPIC (EA2/291/23), to which this ethics application refers.
Participants will be contacted via the mailing list of ESAIC (European Organization for Anaesthesia, Intensive Care, Pain and Perioperative Medicine), ESICM (European Society of Intensive Care Medicine), DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI) and the European Association for Palliative Care (EAPC).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 67 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Doctors or nursing staff involved in the intensive medical care of patients which can be contacted by a list of a specialist association
Key inclusion criteria (1 listed)
- All doctors or nursing staff involved in the intensive medical care of patients and consent to the survey via the distribution list of a specialist association
Key exclusion criteria (1 listed)
- Incomplete data
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Barriers 1
Time frame: 01.04.2024 - 30.06.2024
Barriers in palliative care regarding implementation of therapeutic goals (implementation rate symptom assessment for e.g. breathing and dyspnea).
Barriers 2
Time frame: 01.04.2024 - 30.06.2024
Barriers in palliative care regarding implementation of patient automomy (implementation rate to define advance directives and power of attorney).
4 secondary outcomes
Measures 1
Time frame: 01.04.2024 - 30.06.2024
Measures 2
Time frame: 01.04.2024 - 30.06.2024
Resources 1
Time frame: 01.04.2024 - 30.06.2024
Resources 2
Time frame: 01.04.2024 - 30.06.2024
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Mar 2024.
- Individual participant dataSharing planned: No
Related trials for Palliative Medicine
Enrolling by invitation
Symptom Monitoring Using Patient-Report to Improve Medication Use
Breast Cancer Early Stage Breast Cancer (Stage 1-3), Endocrine Therapy
Not yet recruitingPhase 3
Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management
Cancer Pain, Cancer Palliative Care
RecruitingObservational study
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Neoplasm, Colorectal, Cognitive Impairment
RecruitingObservational study
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
Lennox Gastaut Syndrome
Not yet recruiting
Primary Palliative Care - a Feasibility Cluster Trial
Palliative Care, Primary Palliative Care
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Claudia Spies, MD, Prof. study chair
Charite University, Berlin, Germany
Questions about this trial
What is this clinical trial studying?
An observational study of Palliative Medicine, run by Charite University, Berlin, Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 18 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Barriers 1 (time frame: 01.04.2024 - 30.06.2024). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2024.